Acute cardiac care最新文献

{"title":"A clinical audit of thrombolytic therapy in patients with normotensive pulmonary embolism and intermediate risk.","authors":"Carla Nobre,&nbsp;Dinis Mesquita,&nbsp;Boban Thomas,&nbsp;Teresinha Ponte,&nbsp;Luis Santos,&nbsp;João Tavares","doi":"10.3109/17482941.2014.881503","DOIUrl":"https://doi.org/10.3109/17482941.2014.881503","url":null,"abstract":"<p><strong>Introduction: </strong>There is considerable debate regarding the use of thrombolytic therapy in patients with pulmonary embolism, normal blood pressure and intermediate clinical risk, as defined by right ventricular dysfunction on transthoracic echocardiography or elevated serum markers of cardiac necrosis.</p><p><strong>Aims and objectives: </strong>A clinical audit of normotensive patients diagnosed with acute pulmonary embolism using multi- detector computerized tomography pulmonary angiography (MDCTPA) and intermediate risk, was conducted to determine clinical outcomes at 30 days. The specific role played by imaging findings and clinical severity, on the decision to thrombolyse, was assessed.</p><p><strong>Methods: </strong>The two cohorts who did (n = 15) and did not receive thrombolysis (n = 20) were compared for age, heart rate, blood pressure and oxyhemoglobin saturation at presentation, and the simplified PESI score was calculated in each patient. MDCTPA findings suggestive of adverse clinical outcome including central PE and an increased RV/LV diameter were determined for each patient. RV dysfunction on echocardiography was compared to clinical scoring, and findings on MDCTPA.</p><p><strong>Results: </strong>The patients who received thrombolytic therapy were younger (48.6 ± 19.11 years versus 64.2 ± 13.83 years) (P < 0.01) and had a higher heart rate (107.6 ± 17.1/min versus 91.7 ± 17.8/min) (P < 0.05). More patients with a higher clinical severity, as determined by the simplified PESI score (12/20) and a higher shock index (0.94 ± 0.23), were thrombolysed as compared to the proportion with a lower score (3/15) (P < 0.05) or index (0.70 ± 0.20) (P < 0.005). In-hospital mortality and hemorrhagic complications at 30 days were zero in both groups. RV dysfunction by echocardiography was not a strong determinant for choosing thrombolytic therapy while central PE on MDCTPA tilted the decision towards thrombolysis.</p><p><strong>Conclusion: </strong>Our clinical audit revealed a predilection to use thrombolysis in younger patients with clinical severity and imaging findings on MDCTPA being the key drivers. A perception of a fragile hemodynamic status, as implied by a higher heart rate and shock index, despite a normal BP probably inclined us to thrombolyse.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":" ","pages":"63-6"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2014.881503","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40300144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The association between experience and proficiency with robotic-enhanced coronary intervention-insights from the PRECISE multi-center study.","authors":"Giora Weisz,&nbsp;Nathaniel R Smilowitz,&nbsp;D Christopher Metzger,&nbsp;Ronald Caputo,&nbsp;Juan Delgado,&nbsp;J Jeffrey Marshall,&nbsp;George Vetrovec,&nbsp;Mark Reisman,&nbsp;Ron Waksman,&nbsp;Augusto Pichard,&nbsp;Juan F Granada,&nbsp;Jeffrey W Moses,&nbsp;Joseph P Carrozza","doi":"10.3109/17482941.2014.889314","DOIUrl":"https://doi.org/10.3109/17482941.2014.889314","url":null,"abstract":"<p><strong>Objectives: </strong>The PRECISE multi-center study demonstrated the safety and feasibility of robotic-enhanced coronary intervention (PCI). We studied the learning curve associated with the robotic PCI approach.</p><p><strong>Methods: </strong>The CorPath 200 robotic system was used to perform clinically indicated PCI. The first 3 cases performed by each interventional cardiologist were considered early-experience cases and subsequent procedures were regarded as advanced-experience cases. We compared procedure efficiency, patient radiation exposure, and clinical outcomes in early and advanced-experience cases.</p><p><strong>Results: </strong>A total of 164 robotic-enhanced PCI procedures were performed, with 60 early-experience cases. Advanced-experience cases were associated with shorter procedure duration (51.3 ± 25.5 min vs. 42.2 ± 16.4 min, P = 0.008) and fluoroscopy time (12.9 ± 7.8 min vs. 10.1 ± 4.8 min, 0.009) as compared to early-experience cases.</p><p><strong>Conclusions: </strong>After performing 3 cases, interventionalists were able to complete robotic-enhanced PCI faster, with reduced radiation, and without compromising safety. The steep learning curve highlights the easy adoption of remote-control robotic technology for PCI.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 2","pages":"37-40"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2014.889314","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32197458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Duration of intra-aortic balloon pump use and related complications.","authors":"Konstantinos Dean Boudoulas,&nbsp;Theodore Bowen,&nbsp;Andrew Pederzolli,&nbsp;Kyle Pfahl,&nbsp;Vincent J Pompili,&nbsp;Ernest L Mazzaferri","doi":"10.3109/17482941.2014.889311","DOIUrl":"https://doi.org/10.3109/17482941.2014.889311","url":null,"abstract":"<p><strong>Background: </strong>Intra-aortic balloon pump (IABP) use may be associated with complications; however, in certain patients with ST-elevation myocardial infarction (STEMI) with hemodynamic instability refractory to medical management its use may become necessary.</p><p><strong>Methods: </strong>36 STEMI patients with IABP placement for hemodynamic instability after percutaneous coronary intervention were studied. IABP duration ranged from one to seven days (median two days). Based on median time, patients were divided into two groups: IABP duration ≤ 2 days (n = 27) or > 2 days (n = 9). Vascular complications and incidence of bleeding were compared.</p><p><strong>Results: </strong>Mean IABP duration was 1.4 ± 0.5 and 4.1 ± 1.3 days in ≤ 2 day and > 2 day groups, respectively (P < 0.01). Glycoprotein IIb/IIIa inhibitor and anti-coagulation use was not significantly different between groups. Mean duration of anti-coagulation was 1.9 ± 1.2 and 4.5 ± 1.3 days in ≤ 2 day and > 2 day groups, respectively (P < 0.05). Complications (vascular, access site bleeding, gastrointestinal bleeding) were significantly greater in > 2 day group (66%) compared to ≤ 2 day group (18%; P < 0.05).</p><p><strong>Conclusions: </strong>When an IABP was used for more than two days complications significantly increased. The clinical implications of the study will be strengthened if the findings are confirmed in a prospective study with a larger number of patients.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 2","pages":"74-7"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2014.889311","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32195492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Networks for improving care in patients with acute coronary syndrome: A framework.","authors":"Peter W Radke,&nbsp;Sigrun Halvorsen,&nbsp;J Wouter Jukema,&nbsp;Philippe Kolh,&nbsp;Lieven Annemans,&nbsp;Maarten J Postma,&nbsp;Diego Ardissino,&nbsp;Steen D Kristensen,&nbsp;Jean-Pierre Bassand,&nbsp;Jean-Philippe Collet,&nbsp;João Morais,&nbsp;José Tuñón,&nbsp;Julian Halcox","doi":"10.3109/17482941.2014.881502","DOIUrl":"https://doi.org/10.3109/17482941.2014.881502","url":null,"abstract":"<p><p>In recent years, it has become evident that the level of guideline adherence in patients presenting with acute coronary syndrome (ACS) is highly correlated with patient outcomes. Unfortunately, guideline adherence is low in some geographic areas and especially in those patients at high-risk. Regional networks including ambulance systems and hospitals with catheterization laboratories are able to increase guideline adherence and patient outcomes by streamlining the critical pre- and intra-hospital processes as well as improving timely access to invasive procedures and recommended medication. Successful organization of an ACS network requires engagement of multiple stakeholders to create effective solutions for the specific local setting. There is no 'one-size-fits all' strategy to set-up and successfully run an ACS network. We present a framework for how to set up and organize an effective ACS network, delivering guideline-based care to improve patient outcomes.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 2","pages":"41-8"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2014.881502","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32196068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Initial heart rate and cardiovascular outcomes in patients presenting with acute coronary syndrome.","authors":"Nidal Asaad,&nbsp;Ayman El-Menyar,&nbsp;Khalid F AlHabib,&nbsp;Adel Shabana,&nbsp;Alawi A Alsheikh-Ali,&nbsp;Wael Almahmeed,&nbsp;Hussam Al Faleh,&nbsp;Ahmad Hersi,&nbsp;Shukri Al Saif,&nbsp;Ahmed Al-Motarreb,&nbsp;Kadhim Sulaiman,&nbsp;Khalid Al Nemer,&nbsp;Haitham Amin,&nbsp;Jassim Al Suwaidi","doi":"10.3109/17482941.2014.889312","DOIUrl":"https://doi.org/10.3109/17482941.2014.889312","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the impact of on-admission heart rate (HR) in patients presenting with acute coronary syndrome (ACS).</p><p><strong>Methods: </strong>Data were collected retrospectively from the second Gulf Registry of Acute Coronary Events. Patients were divided according to their initial HR into: (I: < 60, II: 60-69, III: 70-79, IV: 80-89 and V: ≥ 90 bpm). Patients' characteristics and hospital and one- and 12-month outcomes were analyzed and compared.</p><p><strong>Results: </strong>Among 7939 consecutive ACS patients, groups I to V represented 7%, 13%, 20%, 23.5%, and 37%, respectively. Mean age was higher in groups I and V. Group V were more likely males, diabetic and hypertensive. ST-elevation myocardial infarction was the main presentation in groups I and V. Reperfusion therapies were less likely given to group V. Beta blockers were more frequently prescribed to group III in comparison to groups with higher HR. Groups I and V were associated with worse hospital outcomes. Multivariate analysis showed initial tachycardia as an independent predictor for heart failure (OR 2.2; 95%CI: 1.39-3.32), while bradycardia was independently associated with higher one-month mortality (OR 2.0; 95%CI: 1.04-3.85) CONCLUSION: The majority of ACS patients present with tachycardia. However, low or high HR is a marker of high risk that needs more attention and management.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 2","pages":"49-56"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2014.889312","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32236710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to: Strong ion approach in cardiogenic shock: formula and patients.","authors":"Paola Attanà,&nbsp;Chiara Lazzeri,&nbsp;Marco Chiostri,&nbsp;Claudio Picariello,&nbsp;Gian Franco Gensini,&nbsp;Serafina Valente","doi":"10.3109/17482941.2013.859271","DOIUrl":"https://doi.org/10.3109/17482941.2013.859271","url":null,"abstract":"In our opinion, taking into account also these results, our fi nding that ‘ the SIG approach does not seem to add further information in risk stratifi cation ’ appears to be related not to diff erences in formula computation (as inferred by Gatz), but to the ‘ patients ’. In our opinion, the mechanism(s) underlying cardiogenic shock following STEMI are peculiar, diff erent from those accounting for septic shock. It is, therefore, not surprising that the SIG approach may hold a diff erent clinical role in predicting outcomes. Concluding, the unused third decimal number in our formula, diff erently from the original formula, did not change the main result of our study.","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 1","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.859271","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32059824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Takotsubo cardiomyopathy: a review.","authors":"Mahdi Veillet-Chowdhury,&nbsp;Syed Fahad Hassan,&nbsp;Kathleen Stergiopoulos","doi":"10.3109/17482941.2013.869346","DOIUrl":"https://doi.org/10.3109/17482941.2013.869346","url":null,"abstract":"<p><p>Takotsubo cardiomyopathy can occur after acute mental or physical stress, subarachnoid hemorrhage, ischemic stroke, major head trauma, acute medical illness or acute pheochromocytoma crisis. It is characterized by transient systolic dysfunction of the apical and/or midventricular segments in patients without epicardial coronary artery disease. The condition occurs most commonly in postmenopausal women, and is characterized by transient left ventricular dysfunction. The pathophysiology of the disorder remains to be elucidated but may involve catecholamine excess and vasospasm. Future studies, perhaps in the form of an international registry, may clarify the incidence, pathophysiology, clinical course, and prognosis of this disorder.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 1","pages":"15-22"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.869346","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32140388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Distal 'buddy-in-jail' technique: a complementary 'Jail with stent' method for stent delivery.","authors":"Vincent Dangoisse,&nbsp;Antoine Guédès,&nbsp;Erwin Schroëder","doi":"10.3109/17482941.2013.869342","DOIUrl":"https://doi.org/10.3109/17482941.2013.869342","url":null,"abstract":"<p><p>Delivery of coronary stents can be challenging, but the use of a second or 'buddy' wire helps the progression of equipment through tortuous and rigid vessels. We successfully positioned a coronary stent in a distal lesion, intentionally jailing the buddy wire during stent delivery. The jailed wire was then used to proceed further with proximal coronary stenting. We report 10 cases using either the jailed or the non-jailed wire for this modified 'buddy-in-jail' technique.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 1","pages":"28-33"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.869342","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32140390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiac tamponade due to low-volume effusive constrictive pericarditis in a patient with uncontrolled type II autoimmune polyglandular syndrome.","authors":"William C Palmer,&nbsp;Andrew Kurklinsky,&nbsp;Gary Lane,&nbsp;Kamonpun Ussavarungsi,&nbsp;Joseph L Blackshear","doi":"10.3109/17482941.2013.869344","DOIUrl":"https://doi.org/10.3109/17482941.2013.869344","url":null,"abstract":"<p><p>Type II autoimmune polyglandular syndrome (APS), a relatively common endocrine disorder, includes primary adrenal insufficiency coupled with type 1 diabetes mellitus and/or autoimmune primary hypothyroidism. Autoimmune serositis, an associated disease, may present as symptomatic pericardial effusion. We present a case of a 54-year old male with APS who developed pericarditis leading to cardiac tamponade with a subacute loculated effusion. After urgent pericardiocentesis intrapericardial pressure dropped to 0, while central venous pressures remain elevated, consistent with acute effusive constrictive pericarditis. Contrast computerized tomography confirmed increased pericardial contrast enhancement. The patient recovered after prolonged inotropic support and glucocorticoid administration. He re-accumulated the effusion 16 days later, requiring repeat pericardiocentesis. Effusive-constrictive pericarditis, an uncommon pericardial syndrome, is characterized by simultaneous pericardial inflammation and tamponade. Prior cases of APS associated with cardiac tamponade despite low volumes of effusion have been reported, albeit without good demonstration of hemodynamic findings. We report a case of APS with recurrent pericardial effusion due to pericarditis and marked hypotension with comprehensive clinical and hemodynamic assessment. These patients may require aggressive support with pericardiocentesis, inotropes, and hormone replacement therapy. They should be followed closely for recurrent tamponade.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 1","pages":"23-7"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.869344","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32140389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic implications of atrio-ventricular block in patients undergoing primary coronary angioplasty in the stent era.","authors":"Sandra Gómez-Talavera,&nbsp;David Vivas,&nbsp;María Jose Perez-Vizcayno,&nbsp;Rosana Hernández-Antolín,&nbsp;Antonio Fernández-Ortíz,&nbsp;Camino Bañuelos,&nbsp;Javier Escaned,&nbsp;Pilar Jiménez-Quevedo,&nbsp;Dafne Viliani,&nbsp;Isidre Vilacosta,&nbsp;Carlos Macaya,&nbsp;Fernando Alfonso","doi":"10.3109/17482941.2013.869343","DOIUrl":"https://doi.org/10.3109/17482941.2013.869343","url":null,"abstract":"<p><strong>Introduction: </strong>Conduction disorders in patients with ST-segment elevation myocardial infarction (STEMI) are associated with high mortality. Previous studies have analyzed the implications of AVB in acute coronary syndrome treated with fibrinolysis. However, the implications of AVB in patients with STEMI treated with primary angioplasty have not been sufficiently studied.</p><p><strong>Material and methods: </strong>913 patients with STEMI treated with primary angioplasty. All clinical, electrocardiographic and angiographic variables were collected.</p><p><strong>Results: </strong>AVB was documented in 115 patients (12.6%). On admission, AVB was present in 70 (7.7%), and persistent at hospital discharge in 36 (3.9 %). Within these, first-degree AVB was present in 29 (3.2%), second-degree in 27 (3%) and third-degree in 73 (8%). AVB was more frequent in women, elderly, hypertensive, diabetic, with worse functional class (Killip class > 2) and with higher incidence at inferior infarctions (P < 0.05). AVB in general and, more specifically, third-degree AVB was associated with a higher mortality (20.5% versus 5.7%; P < 0.001), re-infarction (8.2% versus 3.6%; P = 0.06) and a greater incidence of cardiogenic shock (33.3% versus 14%; P < 0.001). Interestingly, these events were more common in patients who had persistent AVB at hospital discharge than in those with transitory AVB or present at admission AVB. In the multivariate analysis, persistent AVB at hospital discharge proved to be an independent predictor of cardiovascular events (death and recurrent infarction), not the rest of AVB.</p><p><strong>Conclusions: </strong>AVB in patients who underwent primary angioplasty is associated with a worse prognosis while is in-hospital. This risk is particularly high in patients who had persistent AVB at hospital discharge.</p>","PeriodicalId":87385,"journal":{"name":"Acute cardiac care","volume":"16 1","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/17482941.2013.869343","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32140386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}